A team of Vanderbilt researchers has created a new series of drug candidates against a hard-to-target receptor involved in the formation of blood clots. The research, spearheaded by the labs of Jens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback